Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2021-02-03 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2021-02-03 English
Financial Result Updates
Regulatory Filings
2021-02-02 English
Outcome of Board Meeting
Regulatory Filings
2021-02-02 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is very short (639 characters) and appears to be a letter addressed to the listing departments of the National Stock Exchange of India and BSE Limited. It includes scrip codes and formal salutations but contains no substantive financial data, report content, or detailed disclosures. There is no indication of an actual report or detailed announcement, only a formal communication likely related to listing or compliance. Given the brevity and nature, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-25 English
Updates
Regulatory Filings Classification · 95% confidence The document text contains only references to omitted pictures and no substantive textual content. The total length is only 806 characters, which is very short and does not contain any financial data, report content, or detailed information. There is no indication of a full report, announcement, or any specific filing type. Given the lack of content and the presence of only images (which are omitted), this document does not fit into any detailed report category. According to the rules, such minimal content with no report or announcement text defaults to Regulatory Filings (RNS) as a fallback category.
2021-01-23 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is very short (652 characters) and appears to be a letter addressed to the stock exchanges (NSE and BSE) listing departments. It includes scrip codes and formal salutations but contains no financial data, no detailed report content, and no mention of financial results or management changes. There is no indication of an actual report or detailed announcement. Given the brevity and format, this is likely a regulatory filing or a brief notice rather than a full report or announcement of voting results, dividends, or capital changes. It does not fit into any specific detailed report category and is best classified as a Regulatory Filing (RNS).
2020-12-31 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.